Related Experiment Videos
Attentional vulnerability indicators, thought disorder, and negative symptoms
Schizophrenia Bulletin
|January 1, 1986
Summary
Signal-discrimination deficits are linked to negative symptoms and thought disorder in schizophrenia patients. These attention issues may represent enduring vulnerability factors for schizophrenia, particularly negative symptoms.
Area of Science:
- Neuroscience
- Psychiatry
- Cognitive Psychology
Background:
- Schizophrenia is associated with cognitive deficits, including attention.
- Continuous Performance Tests (CPTs) and span of apprehension tasks assess attentional function.
- These tasks may identify vulnerability factors for schizophrenia.
Purpose of the Study:
- To examine the relationship between signal-discrimination deficits and specific schizophrenic symptoms.
- To investigate the association with formal thought disorder and negative symptoms.
- To assess the persistence of attentional deficits and their link to symptomatology.
Main Methods:
- Assessed 40 inpatient schizophrenic patients using two CPT versions and a span of apprehension task.
- Retested 32 patients as outpatients to evaluate symptom persistence.
- Correlated signal-discrimination performance with symptom ratings (e.g., Brief Psychiatric Rating Scale, Rorschach Thought Disorder Index).
Main Results:
- Signal-discrimination deficits consistently correlated with negative symptoms (Anergia factor) in both inpatient and outpatient settings.
- Outpatient deficits showed correlations with thought disorder measures (Rorschach Thought Disorder Index, BPRS Conceptual Disorganization).
- No significant relationship was found between signal-discrimination deficits and hallucinations or delusions.
Conclusions:
- Signal-discrimination deficits are enduring vulnerability factors for negative symptoms in schizophrenia.
- These deficits may also be associated with specific forms of thought disorder in schizophrenia.
- Findings support the role of effortful processing deficits in the pathophysiology of schizophrenia.